Posted by & filed under Quality Forum 2014, Session Topics.

If you’re interested in antimicrobial stewardship, these sessions might be for you.

C5: There Aren’t Any New Ones – Why Antibiotic Stewardship is Now Essential
This session will describe the calamity of antibiotic resistance in global, national, provincial and local contexts. Participants will leave with a better understanding of new Accreditation Canada requirements, BC Ministry of Health efforts and successful organizational models. Come ready to engage in a lively debate regarding the options for delivery of antibiotic stewardship services in BC.

F1: Building Antimicrobial Stewardship and Engaging Prescribers
Antimicrobial stewardship programs (ASP) are urgently needed in health care facilities (HCF) to provide evidence-based guidance and point of care support for clinicians initiating antimicrobials. ASP is a new required organizational practice for Accreditation Canada. Studies have shown that ongoing support for antimicrobial choice, dose, duration, and route of administration is required. We know that antimicrobial overuse has resulted in preventable adverse drug reactions, increasing Clostridium difficile infections (CDI), and antimicrobial resistance. The time to develop ASP in all health care facilities is now.

F1: Management of Urinary Tract Infections through a Collaborative Approach with Antimicrobial Stewardship and Clinical Improvement Teams
The estimated prevalence of asymptomatic bacteriuria in hospitalized geriatric patients is as high as 50%. At Vancouver General Hospital, clinicians believe that asymptomatic bacteriuria is being misdiagnosed and over treated as urinary tract infections (UTIs), resulting in unnecessary antibiotic treatments. This predisposes patients to adverse events such as Clostridium difficile infection and leads to the development of resistant bacteria and increased health care costs. Vancouver Coastal Health’s Antimicrobial Stewardship team (ASPIRES) aimed to 1) develop objective diagnostic criteria for UTIs and 2) optimize empiric antibiotic treatments based on local bacteria susceptibility patterns.